LRP5 and familial hyperaldosteronism: Here, we provide evidence that bloodstream PBL in young heterozygous FH patients with genetically characterized LDLR mutations have higher expression of LRP5 than age‐matched healthy controls or patients with secondary hypercholesterolaemia.